These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32219704)

  • 1. PFKP is highly expressed in lung cancer and regulates glucose metabolism.
    Shen J; Jin Z; Lv H; Jin K; Jonas K; Zhu C; Chen B
    Cell Oncol (Dordr); 2020 Aug; 43(4):617-629. PubMed ID: 32219704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
    Wang F; Li L; Zhang Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
    Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
    Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFKP phenotype in lung cancer: prognostic potential and beyond.
    Ganapathy-Kanniappan S
    Mol Biol Rep; 2020 Oct; 47(10):8271-8272. PubMed ID: 32915402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth.
    Chen C; Zhang X
    Clin Transl Oncol; 2023 Jul; 25(7):2183-2191. PubMed ID: 36792847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
    Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
    Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
    Lang L; Chemmalakuzhy R; Shay C; Teng Y
    Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells.
    Sha X; Wang K; Wang F; Zhang C; Yang L; Zhu X
    Exp Cell Res; 2021 Oct; 407(1):112789. PubMed ID: 34418458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
    Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
    Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
    Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
    PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
    Inaishi T; Shibata M; Ichikawa T; Kanda M; Hayashi M; Soeda I; Takeuchi D; Takano Y; Tsunoda N; Kodera Y; Kikumori T
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphofructokinase Platelet Overexpression Accelerated Colorectal Cancer Cell Growth and Motility.
    Lu TJ; Yang YF; Cheng CF; Tu YT; Chen YR; Lee MC; Tsai KW
    J Cancer; 2023; 14(6):943-951. PubMed ID: 37151384
    [No Abstract]   [Full Text] [Related]  

  • 13. Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.
    Moon JS; Kim HE; Koh E; Park SH; Jin WJ; Park BW; Park SW; Kim KS
    J Biol Chem; 2011 Jul; 286(27):23808-16. PubMed ID: 21586797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
    Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression.
    Liu W; Ding Z; Tao Y; Liu S; Jiang M; Yi F; Wang Z; Han Y; Zong H; Li D; Zhu Y; Xie Z; Sang S; Chen X; Miao M; Chen X; Lin W; Zhao Y; Zheng G; Zafereo M; Li G; Wu J; Zha X; Liu Y
    Mol Cancer; 2024 Jul; 23(1):141. PubMed ID: 38982480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.
    Lee JH; Liu R; Li J; Zhang C; Wang Y; Cai Q; Qian X; Xia Y; Zheng Y; Piao Y; Chen Q; de Groot JF; Jiang T; Lu Z
    Nat Commun; 2017 Oct; 8(1):949. PubMed ID: 29038421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP.
    Huang Y; Xiong C; Wang C; Deng J; Zuo Z; Wu H; Xiong J; Wu X; Lu H; Hao Q; Zhou X
    Cell Rep; 2023 Nov; 42(11):113426. PubMed ID: 37967006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive prognostic and immunological implications of PFKP in pan-cancer.
    Ling X; Zhang L; Fang C; Liang H; Ma J
    Cancer Cell Int; 2024 Sep; 24(1):310. PubMed ID: 39252014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
    Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
    Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.